IDOX PLC

Declaration of Voting Results & Voting Rights Announcements • Oct 3, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7110O

IDOX PLC

03 October 2019

Idox plc

('Idox' or the 'Group' or the 'Company')

Exercise of Share Options &

Total Voting Rights

Idox plc (AIM: IDOX) a leading supplier of specialist information management solutions and services, announces that it has issued 1,682,927 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to an exercise of options by an employee under its share option plan.

Application has been made for the 1,682,927 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 9 October 2019.

The total number of Ordinary Shares in issue following Admission will be 444,631,006. The Company holds 1,491,219 Ordinary Shares in treasury. Therefore the total number of Ordinary Shares with voting rights in the Company will be 443,139,787.

The above figure of 443,139,787 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

Enquiries:

Idox plc
David Meaden, Chief Executive	+44 (0) 870 333 7101
Rob Grubb, Chief Financial Officer	+44 (0) 333 011 1461
Chris Stone, Chairman	+44 (0) 333 011 1382
N+1 Singer (NOMAD and Broker)	+44 (0) 20 7496 3000
Shaun Dobson
Ben Farrow

About Idox plc

For more information see www.idoxplc.com @Idoxgroup 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRXXLFBKBFBFBD